Literature DB >> 29096531

Ankle-Brachial Index: An Ubiquitous Marker of Cognitive Impairment-The EPIDEMCA Study.

Ileana Desormais1,2, Victor Aboyans1,3, Maëlenn Guerchet1,4, Bébène Ndamba-Bandzouzi5, Pascal Mbelesso6, Dania Mohty1,3, Benoît Marin1,7, Jean Francois Dartigues8, Pierre-Marie Preux1,7, Philippe Lacroix1,2.   

Abstract

Epidemiological research on the implication of atherosclerosis in the development of cognitive impairment is lacking in low- and middle-income countries, where two-thirds of the individuals affected by dementia live. Individuals aged ≥65 years living in urban and rural areas of 2 countries in Central Africa were invited. Demographic, clinical, and biological data were collected, and the ankle-brachial index (ABI) was measured. Cognitive impairment was defined according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria. Among 1662 participants (age 72.9 years, 59.3% females), the prevalence of cognitive impairment was 13.6%, which is higher in individuals with ABI ≤ 0.90 and ABI ≥ 1.40 than those with 0.90 < ABI < 1.40 (20.1% and 17% vs 12%, P = .0024). Cognitive impairment was significantly associated with the factors such as age (odds ratio [OR]: 1.09; 95% confidence interval [CI]: 1.07-1.12, P < .0001), female gender (OR: 2.36, 95% CI: 1.59-3.49, P < .0001), smoking (OR: 1.54, 95% CI: 1.06-2.23, P = .0026), and low ABI (≤0.90; OR: 1.52, 95% CI: 1.03-2.25, P = .0359). The ABI, a ubiquitous marker of atherosclerosis, provides independent and incremental information on susceptibility to present with cognitive disorders.

Entities:  

Keywords:  Africa; ankle–brachial index; atherosclerosis; cognitive impairment; elderly

Mesh:

Year:  2017        PMID: 29096531     DOI: 10.1177/0003319717736608

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  1 in total

1.  The Interaction Effect between Blood Stasis Constitution and Atherosclerotic Factors on Cognitive Impairment in Elderly People.

Authors:  Zhizhen Liu; Hongqing Yang; Mozhu Zhang; Jing Cai; Zijie Huang
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-11       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.